-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Vitro Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and change rate from 2010 to Q4 2024.
- Vitro Biopharma, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Jan 2025 was -$74.000, a 84.8% increase year-over-year.
- Vitro Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$7.22K, a 96.3% increase from 2023.
- Vitro Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$195K, a 37% increase from 2022.
- Vitro Biopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$310K.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)